Filing Details

Accession Number:
0001209191-14-061793
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-10-03 17:01:27
Reporting Period:
2014-10-01
Filing Date:
2014-10-03
Accepted Time:
2014-10-03 17:01:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1373707 Tetraphase Pharmaceuticals Inc TTPH Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1296771 Gordon John Freund 480 Arsenal St, Suite 110
Watertown MA 02472
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-10-01 14,400 $20.41 1,123,480 No 4 S Indirect By Skyline Venture Management IV, LLC
Common Stock Disposition 2014-10-01 127,746 $20.89 995,734 No 4 S Indirect By Skyline Venture Management IV, LLC
Common Stock Disposition 2014-10-02 27,726 $20.72 968,008 No 4 S Indirect By Skyline Venture Management IV, LLC
Common Stock Disposition 2014-10-02 77,862 $21.02 890,146 No 4 S Indirect By Skyline Venture Management IV, LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Skyline Venture Management IV, LLC
No 4 S Indirect By Skyline Venture Management IV, LLC
No 4 S Indirect By Skyline Venture Management IV, LLC
No 4 S Indirect By Skyline Venture Management IV, LLC
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 17, 2014.
  2. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $20.00 to $20.60 per share. The reporting person hereby undertakes, upon request of the staff of the U.S. Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  3. The shares are held by Skyline Venture Partners Qualified Purchaser Fund IV, L.P. ("SVP IV"). The reporting person is a member of Skyline Venture Management IV, LLC, which serves as the sole general partner of SVP IV, and may be deemed to share voting and dispositive power over the shares held by SVP IV. The reporting person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
  4. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $20.61 to $21.20 per share. The reporting person hereby undertakes, upon request of the staff of the U.S. Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  5. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $20.36 to $20.87 per share. The reporting person hereby undertakes, upon request of the staff of the U.S. Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  6. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $20.88 to $21.39 per share. The reporting person hereby undertakes, upon request of the staff of the U.S. Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.